United states - Events
Healthcare is changing faster than we can reactCompanies have had to make billion-dollar bets on AI, manufacturing, organizational models and CRM systems, going against decades of waiting for clarity before committing.
But clarity isn't coming, and patients can't wait. Nor can we.
It's time to stop predicting the future and prepare for all futures. What works across all of them? Patient-centricity and cross-functionality.
Cross-functionality unlocks trapped capabilities. Functional excellence without structural integration fails in today's efficiency-first world. When Medical and Commercial align, omnichannel delivers and launches accelerate. Coordination that consumed months compresses into days. World-class skills finally operate at world-class velocity, built on the technology stacks an…
Novel conjugates have become one of the most competitive and rapidly evolving areas in the precision oncology landscape. Companies are looking beyond traditional ADCs towards novel mechanism of action payloads and differentiated targeting formats for overcoming drug resistance, improved therapeutic windows and to make an impact in cancers which don’t respond to traditional ADCs, as well as the exploration of non-oncology indications.
The 5th Novel Conjugates Summit is the industry’s only dedicated meeting for an insider view into which novel approaches are currently being explored, what benefit each approach has and the directions the space is heading.
Attendees gain valuable competitive insight into emerging technologies, early data, and the rationale behind each approach, from establishe…
The 11th Innate Killer Summit continues its legacy as the world's leading industry meeting dedicated exclusively to advancing NK and innate immune cell therapies.
This year, the summit unites pioneering biotechs, including NKGen, NKILT, Senti Bio, NKore, and leaders from the MD Anderson Rizvani Lab, alongside translational scientists and platform innovators to showcase breakthrough progress in engineering, manufacturing, persistence, tumor targeting, and clinical translation.
As the NK space becomes increasingly competitive and the path to differentiation narrows, this summit stands firmly alongside the global NK community, providing the clarity, collaboration, and momentum needed to keep innovation moving forward.
With in-depth scientific content, real-world clinical insights across six c…
The 8th CRISPR AgBio Congress is the leading forum for AgBiotech innovators, seed companies, growers, consumer food brands, and investors to accelerate the commercialization of gene-edited crops. With USDA easing regulatory pathways and AI revolutionizing trait discovery, now is the time to position your organization at the forefront of sustainable agriculture.
Join industry leaders, including Pairwise, Corteva, Bayer Crop Science, BASF, and more to explore next-generation CRISPR tools, AI-driven target discovery, and strategies for navigating global regulations.
New for 2026: Global Regulations and IP Focus Day, a dedicated Driving Consumer Acceptance Panel, and expanded sessions on AI applications in AgBio.
Be part of the only event combining technical breakthroughs with commercial know-…
Gene therapy is entering a defining new chapter. After a period of challenge and recalibration, the field is regaining momentum, driven by teams who remain steadfast in their belief that this science can transform lives. Confidence is returning, with significant investments and acquisitions signalling a renewed commitment to overcoming barriers of safety, efficacy, and scalability.
The 9th Gene Therapy Development Summit returns to Boston as the meeting point for this community. Join 100+ leading voices from the likes of Bayer, Astellas Pharmaceuticals, REGENXBIO, Ocugen, AskBio, CureDuchenne Ventures, and more to come together to share ideas, restore confidence, and chart a sustainable path forward for gene therapy.
Connect with your peers in pre-clinical development, manufacturing, analy…
CMAC Open Days 2026: Join us 24–26 March 2026 as we celebrate 15 years of CMAC transforming medicines manufacturing.
Discover how Industry 5.0 technologies are shaping the future of medicines manufacturing, with insights into the latest trends, tools, and strategies for creating future-ready, resilient and sustainable manufacturing processes.
At the Open Days you’ll:
🤝 Network with top academics, industry leaders, and researchers
👩🔬 Engage in interactive sessions, lab tours, and poster presentations
💊 Learn about the latest innovations tackling real-world pharmaceutical challenges
🎟️ Registration is now open! Take advantage of early bird rates available until Monday 2 February 2026:
£100 standard (rising to £125 after early bird)
£80 PhD student (rising to £90 after early bird)
To,
I have reached out to you as your research areas/products/services are related to our upcoming conference. Considering the same, our organizing committee would like to invite to be a part of it and you will be a great fit for our upcoming “World Congress on Advances in Applied Science and Engineering” held during 25-26 March 2026. at London, United Kingdom
The WASE 2026 aims to bring together leading researchers, academicians, industry professionals, and policymakers to share innovations, exchange ideas, and foster collaboration across a wide range of topics. We extend warm invitation to you and your organization to be a part of the conference as a Sponsors/Exhibitor/Speaker/Delegate.
Let me know your interest in the same, accordingly I will share y…
LNPs continue to dominate the spotlight in biopharma with three landmark acquisitions in the past six months, AbbVie/Capstan Therapeutics, Eli Lilly and Co/Verve Therapeutics and Bristol Myers Squibb/Orbital Therapeutics. Validating LNPs as a stand-out delivery vehicle for cell and gene therapies!
Returning to Boston in April 2026, the 5th LNP Formulation and Process Development Summit is an industry-led end-to-end meeting providing the latest scientific content to advance LNP development for a variety of payloads and therapeutic applications, from mRNA vaccines to next-generation cell and gene therapies. This is your one-stop shop to hear insights on LNP discovery, analytics, formulation, process development and large-scale manufacturing.
With 3 focused streams, Analytical Development and…
Thought Leader Texas is a premier gathering for executives, innovators, and industry leaders who want to stay ahead of fast-moving shifts in business, leadership, and organizational strategy. This summit brings together experts from across sectors to share fresh perspectives, practical insights, and proven approaches that help leaders navigate today’s most pressing challenges.
Through keynote talks, panel discussions, and interactive sessions, attendees will explore themes such as leadership development, talent and culture, operational excellence, technology adoption, and long-term strategic growth. Each session is designed to offer actionable takeaways-clear ideas and tools executives can bring back to their organizations.
The event also creates space for meaningful networking, allowing l…
The conference features a comprehensive pre-conference focus day dedicated to advancements in device design, followed by a dynamic two-day main conference featuring keynote plenaries, interactive panel discussions, and specialized topic streams covering the most pressing industry challenges and breakthrough solutions including:
Device Innovations for Large Volume and Novel Drug Product DeliveryAdvancing Sustainability in the Injectable Device IndustryPrimary Packaging: Ensuring Safe, Stable, and Biocompatible Combination ProductsPatient-Driven Device Design
Date and Time: Monday, 27 April 2026 at 08:30 - Wednesday, 29 April 2026 at 17:00
Peptide therapies are rapidly becoming a disruptive modality, led by Merck’s oral PCSK9 inhibitor and Johnson and Johnson’s IL23R, with the hope to develop best-in-class drugs with improved chemistry, formulation and clinical efficacy.
To shine a light on the progress of this field, the highly anticipated 3rd Peptide-Based Therapeutics Summit returns to Boston as the industry’s only dedicated platform to turbocharge the next generation of peptide discoveries through development and towards life-saving treatments.
Gathering industry leaders including Parabilis Medicines, Circle Pharma, Abbvie, Merck, Chugai Pharmaceuticals and many more, this is your premium forum to explore:
- Novel computational tools- Optimize analytical assays- Formulating cell-specific delivery methods- DMPK translatab…
The GPCR field is experiencing a renaissance, driven by renewed investment, clinical progress, and next-generation technologies unlocking hundreds of previously untargeted receptors. With rapid advances in structural biology, computation, and screening, the race is on to validate new GPCRs, understand dynamic activation mechanisms, and develop assays that better predict therapeutic efficacy and guide smarter candidate selection.
Returning as the only industry-led meeting dedicated to GPCR drug discovery, the 5th GPCR-Targeted Drug Discovery Summit features a jam-packed agenda featuring new expert voices, and fresh insights spanning the latest targets, tools, and therapeutic strategies.
Join 80+ GPCR-focused leaders across biopharma to share insights, build collaborations, and accelerate ne…
The UK Biotech Day is a leading event for the UK life sciences sector, bringing together executives and R&D scientists from pharma, biotech, medtech, techbio, investors, lawyers, patent attorneys, CROs, CDMOs, accountants, bankers, executive search agencies and others. Serving as a global gateway, it also connects the UK ecosystem with international partners to drive strategic collaborations through dealmaking, innovation, networking and finding new clients and partners.
The Global Infectious Diseases and One Health Conference (GIOH 2026) in London, United Kingdom, Online from August 17–19, 2026, unites health professionals, scientists, and policymakers committed to strengthening preparedness against infectious threats. The One Health congress offers a global perspective on how collaborative efforts can prevent and mitigate disease outbreaks.
Core discussions will focus on pandemic intelligence, surveillance systems, climate-driven infections, biosecurity frameworks, and antibiotic stewardship. Renowned experts will share strategies that enhance early detection, containment, and cross-sector coordination.
Participants will gain access to interactive workshops, expert dialogues, and live demonstrations showcasing new technologies that transform infectious d…
